Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial
2019 ◽
Vol 16
(2)
◽
pp. 388-399
◽
Fabien Zoulim
◽
Claire Fournier
◽
François Habersetzer
◽
Martin Sprinzl
◽
Stanislas Pol
◽
...
2010 ◽
Vol 28
(51)
◽
pp. 8169-8174
◽
Xuan-Yi Wang
◽
Xin-Xin Zhang
◽
Xin Yao
◽
Jie-Hong Jiang
◽
You-Hua Xie
◽
...
1998 ◽
Vol 114
(5)
◽
pp. 988-995
◽
Etienne Marc Sokal
◽
Hari S. Conjeevaram
◽
Eve A. Roberts
◽
Fernando Alvarez
◽
Elana M. Bern
◽
...
Lai Wei
◽
Tingting Zhao
◽
Ji Zhang
◽
Qing Mao
◽
Guozhong Gong
◽
...
1986 ◽
Vol 3
◽
pp. S183-S188
◽
G.J.M. Alexander
◽
E.A. Fagan
◽
P. Guarner
◽
N. Rolando
◽
J. Brahm
◽
...
2013 ◽
Vol 59
(3)
◽
pp. 450-456
◽
Dao-Zhen Xu
◽
Xuan-Yi Wang
◽
Xin-Liang Shen
◽
Guo-Zhong Gong
◽
Hong Ren
◽
...
2018 ◽
Vol 68
◽
pp. S516
◽
A. Julio
◽
J. Aguiar
◽
G. Guillen
◽
E. Penton
◽
G. Fernandez
1989 ◽
Vol 10
(3)
◽
pp. 336-341
◽
Giorgio Saracco
◽
Giuseppe Mazzella
◽
Floriano Rosina
◽
Claudio Cancellieri
◽
Valter Lattore
◽
...
2017 ◽
Vol 15
(1)
◽
pp. e45
Sang-hoon Ahn
◽
Patrick Marcellin
◽
Xiaoli Ma
◽
Florin Caruntu
◽
Won Young Tak
◽
...
2020 ◽
Vol 73
◽
pp. S870-S871
Helene Kerth
◽
Anna Kosinska
◽
Martin Kaechele
◽
Andreas Oswald
◽
Jinpeng Su
◽
...